NASDAQ · Biotechnology

OKUR (OKUR) Stock

$3.95 -2.47% NASDAQ: OKUR Healthcare

Valuation

MetricValue
Price$3.95
Market Cap$54.01M
P/E Ratio-0.72
P/B Ratio0.77
P/S Ratio0.00
EPS (TTM)$-4.40
52-Week High$5.38
52-Week Low$1.91
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-107.14%
ROA-96.77%
ROCE-112.50%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.02
Current Ratio10.17

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-40.0M$-30.0M$-37.0M$-54.0M$-63.0M
Net Profit$-40.0M$-30.0M$-35.0M$-53.0M$-60.0M
EPS$-21.92$-2.21$-2.65$-3.95$-4.40
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$154.0M$16.0M$36.0M$115.0M$62.0M
Total Liabilities$7.0M$70.0M$138.0M$11.0M$6.0M
Cash$125.0M$12.0M$30.0M$111.0M$59.0M
Borrowings$0$1.0M$1.0M$1.0M$1.0M

Latest News

OnKure Therapeutics Spotlights Allosteric PI3Kα Drugs as 2027 IND Targets Near MarketBeat · Jul 15, 2026 OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026 GlobeNewswire · Jul 2, 2026 OnKure Therapeutics Reports First Quarter 2026 Financial Results GlobeNewswire · May 5, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-38.0M$-27.0M$-35.0M$-51.0M$-52.0M
Investing Cash Flow$-24.0M$-2.0M$0$16.0M$0
Financing Cash Flow$0$-1.0M$-1.0M$51.0M$0
Net Cash Flow$71.0M$-2.0M$18.0M$81.0M$-52.0M
Free Cash Flow$-38.0M$-28.0M$-35.0M$-51.0M$-52.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-120.61%
Quick Ratio13.78
Interest Coverage—
Return 1Y68.73%
Return 3Y-94.25%
Return 5Y-95.21%

Ownership

Insiders Held10.48%
Institutions Held76.71%
Institutions Float Held85.69%
Institutional HolderSharesReport Date
RA Capital Management, L.P.3,998,3332026-03-31
Acorn Capital Advisors, LLC 2,839,6742026-03-31
StepStone Group LP2,660,6122026-03-31
Adar1 Capital Management, LLC 2,434,9412026-03-31
Prosight Management, Lp2,154,3812026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About OKUR

OKUR is led by CEO Nicholas A. Saccomano, employs 46 people, headquartered in US, publicly traded since 2021.

OKUR stock trades at $3.95 with a market capitalization of $54.01M. The stock is valued at a price-to-earnings (P/E) ratio of -0.72, price-to-book of 0.77, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.91 and $5.38, and currently trades 26.6% below its 52-week high.

On profitability, OKUR generates a return on equity (ROE) of -107.14%, return on capital employed of -112.50%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides